3D Bioprinting in Medical Market By Products and solutions (Bioprinters, Consumables and accessories, Software and services), By Technology (Extrusion based bioprinting, Inkjet based bioprinting, Laser assisted bioprinting, Others), By Application (Tissue

3D Bioprinting in Medical Market By Products and solutions (Bioprinters, Consumables and accessories, Software and services), By Technology (Extrusion based bioprinting, Inkjet based bioprinting, Laser assisted bioprinting, Others), By Application (Tissue engineering and regenerative medicine, Drug discovery and development, Others), By End users (Biotechnology and pharmaceutical companies, Academic and research institutes, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032


The global 3D bioprinting in medical market was valued at $1.1 billion in 2022, and is projected to reach $4.9 billion by 2032, growing at a CAGR of 15.5% from 2023 to 2032.

3D bioprinting is an advanced technology that involves the deposition of living cells, biomaterials, and other bioactive substances to create three-dimensional structures that mimic the architecture and function of natural tissues and organs. This innovative approach allows for the precise fabrication of complex biological constructs, enabling applications in regenerative medicine, drug testing, and the potential development of functional tissues or organs for transplantation. The process utilizes computer-aided design (CAD) to guide the deposition of bioink, composed of cells and supportive materials, to construct intricate and customized biological structures.  

The 3D bioprinting market is driven by a combination of technological advancements, increasing applications in healthcare and research, rising demand for personalized medicine, and supportive regulatory initiatives. The growing incidence of chronic diseases worldwide, such as heart disease, diabetes, and organ failure, is a significant driver. 3D bioprinting provides a promising avenue for developing replacement tissues and organs for patients suffering from these conditions, thereby driving the market forward. The increase in demand for personalized medicine, which tailors medical treatment to individual patients, fuels the adoption of 3D bioprinting. The ability to create tissues and organs specific to a patient's unique anatomy reduces the risk of rejection and enhances the overall success of transplants, addressing a critical need in healthcare and thereby supporting market growth.  

However, high costs of bioprinters, lack of structured regulatory frameworks related to approvals for 3D bioprinters, copyright & patent infringement concerns, biocompatibility issues of 3D-bioprinted medical devices, and lack of technical expertise are the major factors hampering the growth of the market. Conversely, untapped markets in the developing countries are expected to provide lucrative opportunities for the market players.  

The 3D bioprinting in medical market is segmented into products & solutions, technology, application, end user, and region. By products & solutions, the market is classified into bioprinters, consumables & accessories, and software & services. By technology, the market is classified into extrusion-based bioprinting, inkjet based bioprinting, laser assisted bioprinting, and others. By application, the market is segregated into tissue engineering & regenerative medicine, drug discovery & development, and others. By end user, the market is classified into biotechnology & pharmaceutical companies, academic & research institutes, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).  

Major key players that operate in the global 3D bioprinting in medical market are Organovo Holdings, Inc., Cyfuse Biomedical K.K., BICO, REGEMAT 3D, Desktop Metal, Inc., Medprin, Shining 3D, CollPlant Biotechnologies Ltd, Advanced Solutions, Inc., and 3D Systems Corporation. Key players operating in the market have adopted product launch, partnership, agreement, acquisition, collaboration, expansion, and product upgrade as their key strategies to expand their product portfolio. 

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the 3d bioprinting in medical market analysis from 2022 to 2032 to identify the prevailing 3d bioprinting in medical market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the 3d bioprinting in medical market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global 3d bioprinting in medical market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By End users

Biotechnology and pharmaceutical companies
Academic and research institutes
Others

By Products and solutions

Bioprinters
Consumables and accessories
Software and services

By Technology

Extrusion based bioprinting
Inkjet based bioprinting
Laser assisted bioprinting
Others

By Application

Tissue engineering and regenerative medicine
Drug discovery and development
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
South Africa,
Saudi Arabia
Rest of LAMEA

Key Market Players

Cyfuse Biomedical K.K.
BICO
Desktop Metal, Inc.
Medprin
CollPlant Biotechnologies Ltd
3D Systems Corporation
Organovo Holdings, Inc.
REGEMAT 3D
Shining 3D
Advanced Solutions, Inc.

Please Note: It will take 7-10 business days to complete the report upon order confirmation. 


CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. High intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of chronic diseases
3.4.1.2. Surge in usage of 3D bioprinting in biomedical applications
3.4.1.3. Advancements in 3D bioprinting
3.4.2. Restraints
3.4.2.1. High cost associated with 3D printing
3.4.2.2. Dearth of skilled professionals
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.3.2. Rise in pharmaceutical applications
CHAPTER 4: 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS
4.1. Overview
4.1.1. Market size and forecast
4.2. Bioprinters
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Consumables and accessories
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Software and services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Extrusion based bioprinting
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Inkjet based bioprinting
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Laser assisted bioprinting
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Tissue engineering and regenerative medicine
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Drug discovery and development
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS
7.1. Overview
7.1.1. Market size and forecast
7.2. Biotechnology and pharmaceutical companies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Academic and research institutes
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Others
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: 3D BIOPRINTING IN MEDICAL MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Products and solutions
8.2.3. Market size and forecast, by Technology
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End users
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Products and solutions
8.2.6.1.2. Market size and forecast, by Technology
8.2.6.1.3. Market size and forecast, by Application
8.2.6.1.4. Market size and forecast, by End users
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Products and solutions
8.2.6.2.2. Market size and forecast, by Technology
8.2.6.2.3. Market size and forecast, by Application
8.2.6.2.4. Market size and forecast, by End users
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Products and solutions
8.2.6.3.2. Market size and forecast, by Technology
8.2.6.3.3. Market size and forecast, by Application
8.2.6.3.4. Market size and forecast, by End users
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Products and solutions
8.3.3. Market size and forecast, by Technology
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End users
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Products and solutions
8.3.6.1.2. Market size and forecast, by Technology
8.3.6.1.3. Market size and forecast, by Application
8.3.6.1.4. Market size and forecast, by End users
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Products and solutions
8.3.6.2.2. Market size and forecast, by Technology
8.3.6.2.3. Market size and forecast, by Application
8.3.6.2.4. Market size and forecast, by End users
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Products and solutions
8.3.6.3.2. Market size and forecast, by Technology
8.3.6.3.3. Market size and forecast, by Application
8.3.6.3.4. Market size and forecast, by End users
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Products and solutions
8.3.6.4.2. Market size and forecast, by Technology
8.3.6.4.3. Market size and forecast, by Application
8.3.6.4.4. Market size and forecast, by End users
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Products and solutions
8.3.6.5.2. Market size and forecast, by Technology
8.3.6.5.3. Market size and forecast, by Application
8.3.6.5.4. Market size and forecast, by End users
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Products and solutions
8.3.6.6.2. Market size and forecast, by Technology
8.3.6.6.3. Market size and forecast, by Application
8.3.6.6.4. Market size and forecast, by End users
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Products and solutions
8.4.3. Market size and forecast, by Technology
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End users
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Products and solutions
8.4.6.1.2. Market size and forecast, by Technology
8.4.6.1.3. Market size and forecast, by Application
8.4.6.1.4. Market size and forecast, by End users
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Products and solutions
8.4.6.2.2. Market size and forecast, by Technology
8.4.6.2.3. Market size and forecast, by Application
8.4.6.2.4. Market size and forecast, by End users
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Products and solutions
8.4.6.3.2. Market size and forecast, by Technology
8.4.6.3.3. Market size and forecast, by Application
8.4.6.3.4. Market size and forecast, by End users
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Products and solutions
8.4.6.4.2. Market size and forecast, by Technology
8.4.6.4.3. Market size and forecast, by Application
8.4.6.4.4. Market size and forecast, by End users
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Products and solutions
8.4.6.5.2. Market size and forecast, by Technology
8.4.6.5.3. Market size and forecast, by Application
8.4.6.5.4. Market size and forecast, by End users
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Products and solutions
8.4.6.6.2. Market size and forecast, by Technology
8.4.6.6.3. Market size and forecast, by Application
8.4.6.6.4. Market size and forecast, by End users
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Products and solutions
8.5.3. Market size and forecast, by Technology
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End users
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Products and solutions
8.5.6.1.2. Market size and forecast, by Technology
8.5.6.1.3. Market size and forecast, by Application
8.5.6.1.4. Market size and forecast, by End users
8.5.6.2. South Africa,
8.5.6.2.1. Market size and forecast, by Products and solutions
8.5.6.2.2. Market size and forecast, by Technology
8.5.6.2.3. Market size and forecast, by Application
8.5.6.2.4. Market size and forecast, by End users
8.5.6.3. Saudi Arabia
8.5.6.3.1. Market size and forecast, by Products and solutions
8.5.6.3.2. Market size and forecast, by Technology
8.5.6.3.3. Market size and forecast, by Application
8.5.6.3.4. Market size and forecast, by End users
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Products and solutions
8.5.6.4.2. Market size and forecast, by Technology
8.5.6.4.3. Market size and forecast, by Application
8.5.6.4.4. Market size and forecast, by End users
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Advanced Solutions, Inc.
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Key strategic moves and developments
10.2. CollPlant Biotechnologies Ltd
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Shining 3D
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.4. Organovo Holdings, Inc.
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.4.7. Key strategic moves and developments
10.5. Medprin
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.6. Cyfuse Biomedical K.K.
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.7. Desktop Metal, Inc.
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. REGEMAT 3D
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.9. 3D Systems Corporation
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.9.7. Key strategic moves and developments
10.10. BICO
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
10.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 02. 3D BIOPRINTING IN MEDICAL MARKET FOR BIOPRINTERS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. 3D BIOPRINTING IN MEDICAL MARKET FOR CONSUMABLES AND ACCESSORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. 3D BIOPRINTING IN MEDICAL MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 06. 3D BIOPRINTING IN MEDICAL MARKET FOR EXTRUSION BASED BIOPRINTING, BY REGION, 2022-2032 ($MILLION)
TABLE 07. 3D BIOPRINTING IN MEDICAL MARKET FOR INKJET BASED BIOPRINTING, BY REGION, 2022-2032 ($MILLION)
TABLE 08. 3D BIOPRINTING IN MEDICAL MARKET FOR LASER ASSISTED BIOPRINTING, BY REGION, 2022-2032 ($MILLION)
TABLE 09. 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GLOBAL 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 11. 3D BIOPRINTING IN MEDICAL MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY REGION, 2022-2032 ($MILLION)
TABLE 12. 3D BIOPRINTING IN MEDICAL MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 13. 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. GLOBAL 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 15. 3D BIOPRINTING IN MEDICAL MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 16. 3D BIOPRINTING IN MEDICAL MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
TABLE 17. 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 18. 3D BIOPRINTING IN MEDICAL MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 20. NORTH AMERICA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 21. NORTH AMERICA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 22. NORTH AMERICA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 23. NORTH AMERICA 3D BIOPRINTING IN MEDICAL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 24. U.S. 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 25. U.S. 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 26. U.S. 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 27. U.S. 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 28. CANADA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 29. CANADA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 30. CANADA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 31. CANADA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 32. MEXICO 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 33. MEXICO 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 34. MEXICO 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 35. MEXICO 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 36. EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 37. EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 38. EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 39. EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 40. EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 41. GERMANY 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 42. GERMANY 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 43. GERMANY 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 44. GERMANY 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 45. FRANCE 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 46. FRANCE 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 47. FRANCE 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 48. FRANCE 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 49. UK 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 50. UK 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 51. UK 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 52. UK 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 53. ITALY 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 54. ITALY 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 55. ITALY 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 56. ITALY 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 57. SPAIN 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 58. SPAIN 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 59. SPAIN 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 60. SPAIN 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 61. REST OF EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 62. REST OF EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 63. REST OF EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 64. REST OF EUROPE 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 65. ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 66. ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 67. ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 68. ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 69. ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 70. JAPAN 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 71. JAPAN 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 72. JAPAN 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 73. JAPAN 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 74. CHINA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 75. CHINA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 76. CHINA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 77. CHINA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 78. INDIA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 79. INDIA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 80. INDIA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 81. INDIA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 82. AUSTRALIA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 83. AUSTRALIA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 84. AUSTRALIA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 85. AUSTRALIA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 86. SOUTH KOREA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 87. SOUTH KOREA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 88. SOUTH KOREA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 89. SOUTH KOREA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 93. REST OF ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 94. LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 95. LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 96. LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 97. LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 98. LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 99. BRAZIL 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 100. BRAZIL 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 101. BRAZIL 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 102. BRAZIL 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 103. SOUTH AFRICA, 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 104. SOUTH AFRICA, 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 105. SOUTH AFRICA, 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 106. SOUTH AFRICA, 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 107. SAUDI ARABIA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 108. SAUDI ARABIA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 109. SAUDI ARABIA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 110. SAUDI ARABIA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 111. REST OF LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022-2032 ($MILLION)
TABLE 112. REST OF LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 113. REST OF LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 114. REST OF LAMEA 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022-2032 ($MILLION)
TABLE 115. ADVANCED SOLUTIONS, INC.: KEY EXECUTIVES
TABLE 116. ADVANCED SOLUTIONS, INC.: COMPANY SNAPSHOT
TABLE 117. ADVANCED SOLUTIONS, INC.: PRODUCT SEGMENTS
TABLE 118. ADVANCED SOLUTIONS, INC.: PRODUCT PORTFOLIO
TABLE 119. ADVANCED SOLUTIONS, INC.: KEY STRATERGIES
TABLE 120. COLLPLANT BIOTECHNOLOGIES LTD: KEY EXECUTIVES
TABLE 121. COLLPLANT BIOTECHNOLOGIES LTD: COMPANY SNAPSHOT
TABLE 122. COLLPLANT BIOTECHNOLOGIES LTD: PRODUCT SEGMENTS
TABLE 123. COLLPLANT BIOTECHNOLOGIES LTD: PRODUCT PORTFOLIO
TABLE 124. COLLPLANT BIOTECHNOLOGIES LTD: KEY STRATERGIES
TABLE 125. SHINING 3D: KEY EXECUTIVES
TABLE 126. SHINING 3D: COMPANY SNAPSHOT
TABLE 127. SHINING 3D: PRODUCT SEGMENTS
TABLE 128. SHINING 3D: PRODUCT PORTFOLIO
TABLE 129. ORGANOVO HOLDINGS, INC.: KEY EXECUTIVES
TABLE 130. ORGANOVO HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 131. ORGANOVO HOLDINGS, INC.: PRODUCT SEGMENTS
TABLE 132. ORGANOVO HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 133. ORGANOVO HOLDINGS, INC.: KEY STRATERGIES
TABLE 134. MEDPRIN: KEY EXECUTIVES
TABLE 135. MEDPRIN: COMPANY SNAPSHOT
TABLE 136. MEDPRIN: PRODUCT SEGMENTS
TABLE 137. MEDPRIN: PRODUCT PORTFOLIO
TABLE 138. CYFUSE BIOMEDICAL K.K.: KEY EXECUTIVES
TABLE 139. CYFUSE BIOMEDICAL K.K.: COMPANY SNAPSHOT
TABLE 140. CYFUSE BIOMEDICAL K.K.: PRODUCT SEGMENTS
TABLE 141. CYFUSE BIOMEDICAL K.K.: PRODUCT PORTFOLIO
TABLE 142. DESKTOP METAL, INC.: KEY EXECUTIVES
TABLE 143. DESKTOP METAL, INC.: COMPANY SNAPSHOT
TABLE 144. DESKTOP METAL, INC.: PRODUCT SEGMENTS
TABLE 145. DESKTOP METAL, INC.: PRODUCT PORTFOLIO
TABLE 146. DESKTOP METAL, INC.: KEY STRATERGIES
TABLE 147. REGEMAT 3D: KEY EXECUTIVES
TABLE 148. REGEMAT 3D: COMPANY SNAPSHOT
TABLE 149. REGEMAT 3D: PRODUCT SEGMENTS
TABLE 150. REGEMAT 3D: PRODUCT PORTFOLIO
TABLE 151. 3D SYSTEMS CORPORATION: KEY EXECUTIVES
TABLE 152. 3D SYSTEMS CORPORATION: COMPANY SNAPSHOT
TABLE 153. 3D SYSTEMS CORPORATION: PRODUCT SEGMENTS
TABLE 154. 3D SYSTEMS CORPORATION: PRODUCT PORTFOLIO
TABLE 155. 3D SYSTEMS CORPORATION: KEY STRATERGIES
TABLE 156. BICO: KEY EXECUTIVES
TABLE 157. BICO: COMPANY SNAPSHOT
TABLE 158. BICO: PRODUCT SEGMENTS
TABLE 159. BICO: PRODUCT PORTFOLIO
TABLE 160. BICO: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF 3D BIOPRINTING IN MEDICAL MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN 3D BIOPRINTING IN MEDICAL MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN 3D BIOPRINTING IN MEDICAL MARKET (2023-2032)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. HIGH INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL 3D BIOPRINTING IN MEDICAL MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. 3D BIOPRINTING IN MEDICAL MARKET, BY PRODUCTS AND SOLUTIONS, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR BIOPRINTERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR CONSUMABLES AND ACCESSORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. 3D BIOPRINTING IN MEDICAL MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR EXTRUSION BASED BIOPRINTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR INKJET BASED BIOPRINTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR LASER ASSISTED BIOPRINTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. 3D BIOPRINTING IN MEDICAL MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR TISSUE ENGINEERING AND REGENERATIVE MEDICINE, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. 3D BIOPRINTING IN MEDICAL MARKET, BY END USERS, 2022 AND 2032(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF 3D BIOPRINTING IN MEDICAL MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 28. 3D BIOPRINTING IN MEDICAL MARKET BY REGION, 2022 AND 2032(%)
FIGURE 29. U.S. 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 30. CANADA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 31. MEXICO 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 32. GERMANY 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 33. FRANCE 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 34. UK 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 35. ITALY 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 36. SPAIN 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 37. REST OF EUROPE 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 38. JAPAN 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 39. CHINA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 40. INDIA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 41. AUSTRALIA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 42. SOUTH KOREA 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 43. REST OF ASIA-PACIFIC 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 44. BRAZIL 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)
FIGURE 45. SOUTH AFRICA, 3D BIOPRINTING IN MEDICAL MARKET, 2022-2032 ($MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings